A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation
BackgroundHuman immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with HIV receiving antiretroviral therapy. Antiretroviral treatment suppresses viral load in peripheral tissues but does not e…